APO Research
Talk to an analyst

APO RESEARCH · REPORT

Remicade Biosimilar

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Remicade Biosimilar Industry Growth and Trends Forecast to 2032

19 December 2025113 pages

Choose your research edition.

Industry ResearchRemicade Biosimilar Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Remicade Biosimilar Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Remicade Biosimilar Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Remicade Biosimilar Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Remicade Biosimilar Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Remicade Biosimilar market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Remicade Biosimilar is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Remicade Biosimilar include Walvax Biotechnology, Livzon Pharmaceutical, Hualan Biological Engineering, Hisun Pharmaceutical, Fosun Pharmaceutical, Anke Biotechnology, Synthon Pharmaceuticals, Novartis (Sandoz) and Merck Serono (Merck Group), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Remicade Biosimilar market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Remicade Biosimilar market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Remicade Biosimilar market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Remicade Biosimilar.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Remicade Biosimilar market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Remicade Biosimilar Market by Company

Walvax Biotechnology

Livzon Pharmaceutical

Hualan Biological Engineering

Hisun Pharmaceutical

Fosun Pharmaceutical

Anke Biotechnology

Synthon Pharmaceuticals

Novartis (Sandoz)

Merck Serono (Merck Group)

LG Life Sciences

Hospira

Genentech (Roche Group)

Celltrion

Biogen idec Inc.

Biocon

Remicade Biosimilar Segment by Type

100mg/10ml

500mg/50ml

Remicade Biosimilar Segment by Application

Blood Disorders

Oncology Diseases

Remicade Biosimilar Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remicade Biosimilar market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Remicade Biosimilar and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remicade Biosimilar.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Remicade Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100mg/10ml Table 2. Major Company of 500mg/50ml Table 3. Global Remicade Biosimilar Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 5. Global Remicade Biosimilar Sales Market Share in Volume by Type (2021-2026) Table 6. Global Remicade Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 7. Global Remicade Biosimilar Sales Market Share in Value by Type (2021-2026) Table 8. Global Remicade Biosimilar Price by Type (2021-2026) & (US$/L) Table 9. Global Remicade Biosimilar Sales by Type (2027-2032) & (L) Table 10. Global Remicade Biosimilar Sales Market Share in Volume by Type (2027-2032) Table 11. Global Remicade Biosimilar Sales by Type (2027-2032) & (US$ Million) Table 12. Global Remicade Biosimilar Sales Market Share in Value by Type (2027-2032) Table 13. Global Remicade Biosimilar Price by Type (2027-2032) & (US$/L) Table 14. North America Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 15. North America Remicade Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 17. Europe Remicade Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 19. Asia-Pacific Remicade Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 21. Latin America Remicade Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Remicade Biosimilar Sales by Type (2021-2026) & (L) Table 23. Middle East and Africa Remicade Biosimilar Sales by Type (2021-2026) & (US$ Million) Table 24. Remicade Biosimilar Industry Trends Table 25. Remicade Biosimilar Industry Drivers Table 26. Remicade Biosimilar Industry Opportunities and Challenges Table 27. Remicade Biosimilar Industry Restraints Table 28. Global Remicade Biosimilar Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Remicade Biosimilar Revenue Market Share by Company (2021-2026) Table 30. Global Remicade Biosimilar Sales by Company (2021-2026) & (L) Table 31. Global Remicade Biosimilar Sales Share by Company (2021-2026) Table 32. Global Remicade Biosimilar Market Price by Company (2021-2026) & (US$/L) Table 33. Global Remicade Biosimilar Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Remicade Biosimilar Major Company Production Sites and Headquarters Table 35. Global Remicade Biosimilar Company, Product Type & Application Table 36. Global Remicade Biosimilar Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Remicade Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Remicade Biosimilar Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Remicade Biosimilar Sales by Region (2021-2026) & (L) Table 41. Global Remicade Biosimilar Sales Market Share in Volume by Region (2021-2026) Table 42. Global Remicade Biosimilar Sales by Region (2021-2026) & (US$ Million) Table 43. Global Remicade Biosimilar Sales Market Share in Value by Region (2021-2026) Table 44. Global Remicade Biosimilar Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 45. Global Remicade Biosimilar Sales by Region (2027-2032) & (L) Table 46. Global Remicade Biosimilar Sales Market Share in Volume by Region (2027-2032) Table 47. Global Remicade Biosimilar Sales by Region (2027-2032) & (US$ Million) Table 48. Global Remicade Biosimilar Sales Market Share in Value by Region (2027-2032) Table 49. Global Remicade Biosimilar Sales (L), Value (US$ Million), Price (US$/L) and Gross Margin (2027-2032) Table 50. Global Remicade Biosimilar Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 52. Global Remicade Biosimilar Sales Market Share in Volume by Application (2021-2026) Table 53. Global Remicade Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 54. Global Remicade Biosimilar Sales Market Share in Value by Application (2021-2026) Table 55. Global Remicade Biosimilar Price by Application (2021-2026) & (US$/L) Table 56. Global Remicade Biosimilar Sales by Application (2027-2032) & (L) Table 57. Global Remicade Biosimilar Sales Market Share in Volume by Application (2027-2032) Table 58. Global Remicade Biosimilar Sales by Application (2027-2032) & (US$ Million) Table 59. Global Remicade Biosimilar Sales Market Share in Value by Application (2027-2032) Table 60. Global Remicade Biosimilar Price by Application (2027-2032) & (US$/L) Table 61. North America Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 62. North America Remicade Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 64. Europe Remicade Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 66. Asia-Pacific Remicade Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 68. Latin America Remicade Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Remicade Biosimilar Sales by Application (2021-2026) & (L) Table 70. Middle East and Africa Remicade Biosimilar Sales by Application (2021-2026) & (US$ Million) Table 71. Walvax Biotechnology Company Information Table 72. Walvax Biotechnology Business Overview Table 73. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 74. Walvax Biotechnology Remicade Biosimilar Product Portfolio Table 75. Walvax Biotechnology Recent Development Table 76. Livzon Pharmaceutical Company Information Table 77. Livzon Pharmaceutical Business Overview Table 78. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 79. Livzon Pharmaceutical Remicade Biosimilar Product Portfolio Table 80. Livzon Pharmaceutical Recent Development Table 81. Hualan Biological Engineering Company Information Table 82. Hualan Biological Engineering Business Overview Table 83. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 84. Hualan Biological Engineering Remicade Biosimilar Product Portfolio Table 85. Hualan Biological Engineering Recent Development Table 86. Hisun Pharmaceutical Company Information Table 87. Hisun Pharmaceutical Business Overview Table 88. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 89. Hisun Pharmaceutical Remicade Biosimilar Product Portfolio Table 90. Hisun Pharmaceutical Recent Development Table 91. Fosun Pharmaceutical Company Information Table 92. Fosun Pharmaceutical Business Overview Table 93. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 94. Fosun Pharmaceutical Remicade Biosimilar Product Portfolio Table 95. Fosun Pharmaceutical Recent Development Table 96. Anke Biotechnology Company Information Table 97. Anke Biotechnology Business Overview Table 98. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 99. Anke Biotechnology Remicade Biosimilar Product Portfolio Table 100. Anke Biotechnology Recent Development Table 101. Synthon Pharmaceuticals Company Information Table 102. Synthon Pharmaceuticals Business Overview Table 103. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 104. Synthon Pharmaceuticals Remicade Biosimilar Product Portfolio Table 105. Synthon Pharmaceuticals Recent Development Table 106. Novartis (Sandoz) Company Information Table 107. Novartis (Sandoz) Business Overview Table 108. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 109. Novartis (Sandoz) Remicade Biosimilar Product Portfolio Table 110. Novartis (Sandoz) Recent Development Table 111. Merck Serono (Merck Group) Company Information Table 112. Merck Serono (Merck Group) Business Overview Table 113. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 114. Merck Serono (Merck Group) Remicade Biosimilar Product Portfolio Table 115. Merck Serono (Merck Group) Recent Development Table 116. LG Life Sciences Company Information Table 117. LG Life Sciences Business Overview Table 118. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 119. LG Life Sciences Remicade Biosimilar Product Portfolio Table 120. LG Life Sciences Recent Development Table 121. Hospira Company Information Table 122. Hospira Business Overview Table 123. Hospira Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 124. Hospira Remicade Biosimilar Product Portfolio Table 125. Hospira Recent Development Table 126. Genentech (Roche Group) Company Information Table 127. Genentech (Roche Group) Business Overview Table 128. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 129. Genentech (Roche Group) Remicade Biosimilar Product Portfolio Table 130. Genentech (Roche Group) Recent Development Table 131. Celltrion Company Information Table 132. Celltrion Business Overview Table 133. Celltrion Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 134. Celltrion Remicade Biosimilar Product Portfolio Table 135. Celltrion Recent Development Table 136. Biogen idec Inc. Company Information Table 137. Biogen idec Inc. Business Overview Table 138. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 139. Biogen idec Inc. Remicade Biosimilar Product Portfolio Table 140. Biogen idec Inc. Recent Development Table 141. Biocon Company Information Table 142. Biocon Business Overview Table 143. Biocon Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 144. Biocon Remicade Biosimilar Product Portfolio Table 145. Biocon Recent Development Table 146. North America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 147. North America Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 148. North America Remicade Biosimilar Sales Market Share by Country (2021-2026) Table 149. North America Remicade Biosimilar Sales Forecast by Country (2027-2032) & (L) Table 150. North America Remicade Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 151. North America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Remicade Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Remicade Biosimilar Market Share by Country (2021-2026) Table 154. North America Remicade Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Remicade Biosimilar Market Share Forecast by Country (2027-2032) Table 156. Europe Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 157. Europe Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 158. Europe Remicade Biosimilar Sales Market Share by Country (2021-2026) Table 159. Europe Remicade Biosimilar Sales Forecast by Country (2027-2032) & (L) Table 160. Europe Remicade Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Remicade Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Remicade Biosimilar Market Share by Country (2021-2026) Table 164. Europe Remicade Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Remicade Biosimilar Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 168. Asia-Pacific Remicade Biosimilar Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Remicade Biosimilar Sales Forecast by Country (2027-2032) & (L) Table 170. Asia-Pacific Remicade Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Remicade Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Remicade Biosimilar Market Share by Country (2021-2026) Table 174. Asia-Pacific Remicade Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Remicade Biosimilar Market Share Forecast by Country (2027-2032) Table 176. Latin America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 177. Latin America Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 178. Latin America Remicade Biosimilar Sales Market Share by Country (2021-2026) Table 179. Latin America Remicade Biosimilar Sales Forecast by Country (2027-2032) & (L) Table 180. Latin America Remicade Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Remicade Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Remicade Biosimilar Market Share by Country (2021-2026) Table 184. Latin America Remicade Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Remicade Biosimilar Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Remicade Biosimilar Sales by Country (2021-2026) & (L) Table 188. Middle East and Africa Remicade Biosimilar Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Remicade Biosimilar Sales Forecast by Country (2027-2032) & (L) Table 190. Middle East and Africa Remicade Biosimilar Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Remicade Biosimilar Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Remicade Biosimilar Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Remicade Biosimilar Market Share by Country (2021-2026) Table 194. Middle East and Africa Remicade Biosimilar Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Remicade Biosimilar Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Remicade Biosimilar Distributors List Table 199. Remicade Biosimilar Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Remicade Biosimilar Image Figure 2. Global Remicade Biosimilar Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Remicade Biosimilar Market Size (2021-2032) & (US$ Million) Figure 4. Global Remicade Biosimilar Sales (2021-2032) & (L) Figure 5. 100mg/10ml Image Figure 6. Global 100mg/10ml Sales YoY Growth (2021-2032) & (L) Figure 7. 500mg/50ml Image Figure 8. Global 500mg/50ml Sales YoY Growth (2021-2032) & (L) Figure 9. Global Remicade Biosimilar Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Remicade Biosimilar Market Share by Type 2025 VS 2032 Figure 11. North America Remicade Biosimilar Sales Market Share in Volume by Type in 2025 Figure 12. North America Remicade Biosimilar Sales Market Share in Value by Type in 2025 Figure 13. Europe Remicade Biosimilar Sales Market Share in Volume by Type in 2025 Figure 14. Europe Remicade Biosimilar Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Remicade Biosimilar Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Remicade Biosimilar Sales Market Share in Value by Type in 2025 Figure 17. Latin America Remicade Biosimilar Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Remicade Biosimilar Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Remicade Biosimilar Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Remicade Biosimilar Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Remicade Biosimilar Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Blood Disorders Image Figure 24. Global Blood Disorders Sales YoY Growth (2021-2032) & (L) Figure 25. Oncology Diseases Image Figure 26. Global Oncology Diseases Sales YoY Growth (2021-2032) & (L) Figure 27. Global Remicade Biosimilar Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Remicade Biosimilar Market Share by Application 2025 VS 2032 Figure 29. North America Remicade Biosimilar Sales Market Share in Volume by Application in 2025 Figure 30. North America Remicade Biosimilar Sales Market Share in Value by Application in 2025 Figure 31. Europe Remicade Biosimilar Sales Market Share in Volume by Application in 2025 Figure 32. Europe Remicade Biosimilar Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Remicade Biosimilar Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Remicade Biosimilar Sales Market Share in Value by Application in 2025 Figure 35. Latin America Remicade Biosimilar Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Remicade Biosimilar Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Remicade Biosimilar Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Remicade Biosimilar Sales Market Share in Value by Application in 2025 Figure 39. North America Remicade Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 40. North America Remicade Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Remicade Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Remicade Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Remicade Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 44. Europe Remicade Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Remicade Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Remicade Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Remicade Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 48. Asia-Pacific Remicade Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Remicade Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Remicade Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Remicade Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 52. Latin America Remicade Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Remicade Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Remicade Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Remicade Biosimilar Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 56. Middle East and Africa Remicade Biosimilar Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Remicade Biosimilar Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Remicade Biosimilar Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Remicade Biosimilar Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Remicade Biosimilar Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/10ml
  • 500mg/50ml
Applications
  • Blood Disorders
  • Oncology Diseases
Companies covered
  • Walvax Biotechnology
  • Livzon Pharmaceutical
  • Hualan Biological Engineering
  • Hisun Pharmaceutical
  • Fosun Pharmaceutical
  • Anke Biotechnology
  • Synthon Pharmaceuticals
  • Novartis (Sandoz)
  • Merck Serono (Merck Group)
  • LG Life Sciences
  • Hospira
  • Genentech (Roche Group)
  • Celltrion
  • Biogen idec Inc.
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Remicade Biosimilar Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Remicade Biosimilar Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Remicade Biosimilar Market by Type
  6. 1.3.1 100mg/10ml
  7. 1.3.2 500mg/50ml
  8. 1.4 Global Remicade Biosimilar Market Size by Type
  9. 1.4.1 Global Remicade Biosimilar Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Remicade Biosimilar Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Remicade Biosimilar Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Remicade Biosimilar Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Remicade Biosimilar Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Remicade Biosimilar Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Remicade Biosimilar Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Remicade Biosimilar Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Remicade Biosimilar Industry Trends
  2. 2.2 Remicade Biosimilar Industry Drivers
  3. 2.3 Remicade Biosimilar Industry Opportunities and Challenges
  4. 2.4 Remicade Biosimilar Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Remicade Biosimilar Revenue (2021-2026)
  2. 3.2 Global Top Players by Remicade Biosimilar Sales (2021-2026)
  3. 3.3 Global Top Players by Remicade Biosimilar Price (2021-2026)
  4. 3.4 Global Remicade Biosimilar Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Remicade Biosimilar Major Company Production Sites & Headquarters
  6. 3.6 Global Remicade Biosimilar Company, Product Type & Application
  7. 3.7 Global Remicade Biosimilar Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Remicade Biosimilar Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Remicade Biosimilar Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Remicade Biosimilar Tier 1, Tier 2, and Tier 3
4 Remicade Biosimilar Regional Status and Outlook
  1. 4.1 Global Remicade Biosimilar Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Remicade Biosimilar Historic Market Size by Region
  3. 4.2.1 Global Remicade Biosimilar Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Remicade Biosimilar Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Remicade Biosimilar Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Remicade Biosimilar Forecasted Market Size by Region
  7. 4.3.1 Global Remicade Biosimilar Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Remicade Biosimilar Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Remicade Biosimilar Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Remicade Biosimilar by Application
  1. 5.1 Remicade Biosimilar Market by Application
  2. 5.1.1 Blood Disorders
  3. 5.1.2 Oncology Diseases
  4. 5.2 Global Remicade Biosimilar Market Size by Application
  5. 5.2.1 Global Remicade Biosimilar Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Remicade Biosimilar Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Remicade Biosimilar Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Remicade Biosimilar Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Remicade Biosimilar Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Remicade Biosimilar Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Remicade Biosimilar Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Remicade Biosimilar Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Walvax Biotechnology
  2. 6.1.1 Walvax Biotechnology Company Information
  3. 6.1.2 Walvax Biotechnology Business Overview
  4. 6.1.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Walvax Biotechnology Remicade Biosimilar Product Portfolio
  6. 6.1.5 Walvax Biotechnology Recent Developments
  7. 6.2 Livzon Pharmaceutical
  8. 6.2.1 Livzon Pharmaceutical Company Information
  9. 6.2.2 Livzon Pharmaceutical Business Overview
  10. 6.2.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Livzon Pharmaceutical Remicade Biosimilar Product Portfolio
  12. 6.2.5 Livzon Pharmaceutical Recent Developments
  13. 6.3 Hualan Biological Engineering
  14. 6.3.1 Hualan Biological Engineering Company Information
  15. 6.3.2 Hualan Biological Engineering Business Overview
  16. 6.3.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hualan Biological Engineering Remicade Biosimilar Product Portfolio
  18. 6.3.5 Hualan Biological Engineering Recent Developments
  19. 6.4 Hisun Pharmaceutical
  20. 6.4.1 Hisun Pharmaceutical Company Information
  21. 6.4.2 Hisun Pharmaceutical Business Overview
  22. 6.4.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hisun Pharmaceutical Remicade Biosimilar Product Portfolio
  24. 6.4.5 Hisun Pharmaceutical Recent Developments
  25. 6.5 Fosun Pharmaceutical
  26. 6.5.1 Fosun Pharmaceutical Company Information
  27. 6.5.2 Fosun Pharmaceutical Business Overview
  28. 6.5.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fosun Pharmaceutical Remicade Biosimilar Product Portfolio
  30. 6.5.5 Fosun Pharmaceutical Recent Developments
  31. 6.6 Anke Biotechnology
  32. 6.6.1 Anke Biotechnology Company Information
  33. 6.6.2 Anke Biotechnology Business Overview
  34. 6.6.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Anke Biotechnology Remicade Biosimilar Product Portfolio
  36. 6.6.5 Anke Biotechnology Recent Developments
  37. 6.7 Synthon Pharmaceuticals
  38. 6.7.1 Synthon Pharmaceuticals Company Information
  39. 6.7.2 Synthon Pharmaceuticals Business Overview
  40. 6.7.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Synthon Pharmaceuticals Remicade Biosimilar Product Portfolio
  42. 6.7.5 Synthon Pharmaceuticals Recent Developments
  43. 6.8 Novartis (Sandoz)
  44. 6.8.1 Novartis (Sandoz) Company Information
  45. 6.8.2 Novartis (Sandoz) Business Overview
  46. 6.8.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novartis (Sandoz) Remicade Biosimilar Product Portfolio
  48. 6.8.5 Novartis (Sandoz) Recent Developments
  49. 6.9 Merck Serono (Merck Group)
  50. 6.9.1 Merck Serono (Merck Group) Company Information
  51. 6.9.2 Merck Serono (Merck Group) Business Overview
  52. 6.9.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Serono (Merck Group) Remicade Biosimilar Product Portfolio
  54. 6.9.5 Merck Serono (Merck Group) Recent Developments
  55. 6.10 LG Life Sciences
  56. 6.10.1 LG Life Sciences Company Information
  57. 6.10.2 LG Life Sciences Business Overview
  58. 6.10.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LG Life Sciences Remicade Biosimilar Product Portfolio
  60. 6.10.5 LG Life Sciences Recent Developments
  61. 6.11 Hospira
  62. 6.11.1 Hospira Company Information
  63. 6.11.2 Hospira Business Overview
  64. 6.11.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hospira Remicade Biosimilar Product Portfolio
  66. 6.11.5 Hospira Recent Developments
  67. 6.12 Genentech (Roche Group)
  68. 6.12.1 Genentech (Roche Group) Company Information
  69. 6.12.2 Genentech (Roche Group) Business Overview
  70. 6.12.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Genentech (Roche Group) Remicade Biosimilar Product Portfolio
  72. 6.12.5 Genentech (Roche Group) Recent Developments
  73. 6.13 Celltrion
  74. 6.13.1 Celltrion Company Information
  75. 6.13.2 Celltrion Business Overview
  76. 6.13.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Celltrion Remicade Biosimilar Product Portfolio
  78. 6.13.5 Celltrion Recent Developments
  79. 6.14 Biogen idec Inc.
  80. 6.14.1 Biogen idec Inc. Company Information
  81. 6.14.2 Biogen idec Inc. Business Overview
  82. 6.14.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Biogen idec Inc. Remicade Biosimilar Product Portfolio
  84. 6.14.5 Biogen idec Inc. Recent Developments
  85. 6.15 Biocon
  86. 6.15.1 Biocon Company Information
  87. 6.15.2 Biocon Business Overview
  88. 6.15.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Biocon Remicade Biosimilar Product Portfolio
  90. 6.15.5 Biocon Recent Developments
7 North America by Country
  1. 7.1 North America Remicade Biosimilar Sales by Country
  2. 7.1.1 North America Remicade Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Remicade Biosimilar Sales by Country (2021-2026)
  4. 7.1.3 North America Remicade Biosimilar Sales Forecast by Country (2027-2032)
  5. 7.2 North America Remicade Biosimilar Market Size by Country
  6. 7.2.1 North America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Remicade Biosimilar Market Size by Country (2021-2026)
  8. 7.2.3 North America Remicade Biosimilar Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Remicade Biosimilar Sales by Country
  2. 8.1.1 Europe Remicade Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Remicade Biosimilar Sales by Country (2021-2026)
  4. 8.1.3 Europe Remicade Biosimilar Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Remicade Biosimilar Market Size by Country
  6. 8.2.1 Europe Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Remicade Biosimilar Market Size by Country (2021-2026)
  8. 8.2.3 Europe Remicade Biosimilar Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Remicade Biosimilar Sales by Country
  2. 9.1.1 Asia-Pacific Remicade Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Remicade Biosimilar Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Remicade Biosimilar Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Remicade Biosimilar Market Size by Country
  6. 9.2.1 Asia-Pacific Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Remicade Biosimilar Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Remicade Biosimilar Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Remicade Biosimilar Sales by Country
  2. 10.1.1 South America Remicade Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Remicade Biosimilar Sales by Country (2021-2026)
  4. 10.1.3 South America Remicade Biosimilar Sales Forecast by Country (2027-2032)
  5. 10.2 South America Remicade Biosimilar Market Size by Country
  6. 10.2.1 South America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Remicade Biosimilar Market Size by Country (2021-2026)
  8. 10.2.3 South America Remicade Biosimilar Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Remicade Biosimilar Sales by Country
  2. 11.1.1 Middle East and Africa Remicade Biosimilar Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Remicade Biosimilar Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Remicade Biosimilar Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Remicade Biosimilar Market Size by Country
  6. 11.2.1 Middle East and Africa Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Remicade Biosimilar Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Remicade Biosimilar Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Remicade Biosimilar Value Chain Analysis
  2. 12.1.1 Remicade Biosimilar Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Remicade Biosimilar Production Mode & Process
  7. 12.2 Remicade Biosimilar Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Remicade Biosimilar Distributors
  10. 12.2.3 Remicade Biosimilar Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst